Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Celebrity paid partnerships with Pfizer raises questions

Por: Newsweek Health January 18, 2023

thumbnail

A host of celebrities are facing scrutiny on social media after promoting Pfizer's COVID-19 vaccine in paid partnerships on their respective Instagram accounts over the past week.In the past few days, musicians Pink and Questlove, actor Jean Smart, and Olympic gold medalist Michael Phelps have each taken to Instagram to share sponsored posts in which they have spoken about the vaccine.As part of pharmaceutical giant Pfizer's Know Plan... + full article



Similar News

Pfizer accused of obscene COVID profits after posting record revenues

Newsweek USA Business February 02, 2023

thumbnailPharmaceutical giant Pfizer has been accused of making an obscene profit from the coronavirus pandemic after it posted record revenue of more than $100 billion for 2022, a rise of 23 percent on the previous year.The company's COVID products Comirnaty, an mRNA vaccine and... + más

Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC

Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC


Drugmaker Pfizer starts low with 2023 earnings forecast

Associated Press USA Business January 31, 2023

Pfizer surprised Wall Street by predicting a bigger-than-expected sales drop this year for two key products: its COVID-19 vaccine and treatment.The drugmaker also released an earnings forecast that starts off below analyst expectations, sending shares lower before the opening... + más

Fact Check: Were the Grammys sponsored by Pfizer? | Newsweek

Pfizer says COVID-19 vaccine will cost $110-$130 per dose | ABC News


Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history

CNBC USA Health December 06, 2022

thumbnailVials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge


Vacation Inspiration: Celebrity Cruises Has Epic New Sailings For 2024-25

Forbes USA Life November 28, 2022

thumbnailannounced its new cruise offerings for 2024-25 and there’s plenty to entice. Now’s an ideal time to plan vacations not only for next year but beyond and you’re sure to find the right cruise for you with Celebrity. Whether you want to relax and recharge, see multiple... + más

20+ Black Friday And Cyber Monday Cruise Deals For Major Vacation Savings | Forbes

All major cruise lines will soon allow unvaccinated travelers | Portland Press Herald


Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven

MarketWatch USA Business November 26, 2022

thumbnailRosenberg has been interviewed many times by Barron’s and has made some prescient calls. In late 2011, he compared (MSFT) favorably to (IBM), which had then drawn a big investment from (BRK.A). “Warren Buffett came pretty late to the IBM party,” he said. Microsoft is up... + más

Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven | MarketWatch

Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC


Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven

MarketWatch USA Business November 26, 2022

thumbnailRosenberg has been interviewed many times by Barron’s and has made some prescient calls. In late 2011, he compared (MSFT) favorably to (IBM), which had then drawn a big investment from (BRK.A). “Warren Buffett came pretty late to the IBM party,” he said. Microsoft is up... + más

Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven | MarketWatch

Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC


Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics

CNBC USA Health November 02, 2022

thumbnailPfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más

Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC

Pfizer climbs on strong Q3 results, raised outlook | MarketWatch



About iurex | Privacy Policy | Disclaimer |